Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
105 participants
INTERVENTIONAL
2025-07-08
2025-11-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Diabetes Care With Patient Decision Aids - A Trial in Community-based Primary Care
NCT00668590
Evaluation of a Digital Diabetes Self-Management Education and Support Program
NCT05368454
Diabetes To Go: An Inpatient Diabetes Survival Skills Education Program
NCT03023228
Assessing Health Outcomes in Low-income Diabetics Who Receive Monthly Boxes of Healthy Food at Clinic
NCT02917902
The Management of Diabetes in Everyday Life Program
NCT02957513
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Initial text, follow-up text, letter
Participants are initially randomized to glycemic screening invitations by text, and then if they are not screened within 30 days, then they are re-rerandomized to another glycemic screening invitation by text. If they are still not screened in another 30 days then they receive a mailed letter encouraging glycemic screening.
Text message
Participants receive a text message encouraging glycemic screening
Mailed letter
Participants receive a mailed letter encouraging glycemic screening
Initial portal, follow-up portal, letter
Participants are initially randomized to glycemic screening invitations by patient portal, and then if they are not screened within 30 days, then they are re-rerandomized to another glycemic screening invitation by patient portal. If they are still not screened in another 30 days then they receive a mailed letter encouraging glycemic screening.
Patient portal message
Participants receive a patient portal message encouraging glycemic screening
Mailed letter
Participants receive a mailed letter encouraging glycemic screening
Initial text, follow-up portal, letter
Participants are initially randomized to glycemic screening invitations by text, and then if they are not screened within 30 days, then they are re-rerandomized to another glycemic screening invitation by patient portal. If they are still not screened in another 30 days then they receive a mailed letter encouraging glycemic screening.
Text message
Participants receive a text message encouraging glycemic screening
Patient portal message
Participants receive a patient portal message encouraging glycemic screening
Mailed letter
Participants receive a mailed letter encouraging glycemic screening
Initial portal, follow-up text, letter
Participants are initially randomized to glycemic screening invitations by patient portal, and then if they are not screened within 30 days, then they are re-rerandomized to another glycemic screening invitation by text. If they are still not screened in another 30 days then they receive a mailed letter encouraging glycemic screening.
Text message
Participants receive a text message encouraging glycemic screening
Patient portal message
Participants receive a patient portal message encouraging glycemic screening
Mailed letter
Participants receive a mailed letter encouraging glycemic screening
Usual care
Patients do not receive any glycemic screening invitations
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Text message
Participants receive a text message encouraging glycemic screening
Patient portal message
Participants receive a patient portal message encouraging glycemic screening
Mailed letter
Participants receive a mailed letter encouraging glycemic screening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
35 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kenrik Duru
Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Obidiugwu K Duru, MD, MS
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Los Angeles
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-24-6330
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.